Brief: Bavarian Nordic, Serum Institute Of India Expand Strategic Partnership
March 11 (Reuters) - Bavarian Nordic A/S BAVA.CO: BAVARIAN NORDIC AND SERUM INSTITUTE OF INDIA EXPAND STRATEGIC PARTNERSHIP WITH CHIKUNGUNYA VACCINE MANUFACTURING AGREEMENT AGREEMENT ENABLES FUTURE SUPPLY OF CHIKUNGUNYA VACCINE TO LOW- AND MIDDLE-INCOME COUNTRIES AGREEMENT REPLACES PREVIOUS DEAL WITH BIOLOGICAL E. LIMITED Source text: ID:nGNE6RGs2y Further company coverage: BAVA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Completes First Tranche Of Share Buy-Back Program
Bavarian Nordic gets four-year contract for mpox and smallpox vaccine from UK government
Brief: Bavarian Nordic Awarded Multi-Year Vaccine Contract By UK Government
Bavarian Nordic donates 75,000 mpox vaccine doses to global emergency stockpile
Brief: Bavarian Nordic Donates To Global Mpox Emergency Stockpile